Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.70
Bid: 5.60
Ask: 6.20
Change: 0.00 (0.00%)
Spread: 0.60 (10.714%)
Open: 5.70
High: 0.00
Low: 0.00
Prev. Close: 5.70
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PREtec Products Submitted for Regulatory Approval

25 Sep 2023 07:00

RNS Number : 4159N
Plant Health Care PLC
25 September 2023
 

25 September 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

New PREtec Products Submitted for Regulatory Approval

 

PHC25279 and PHC68949 submitted for approval in Mexico

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce it has submitted applications to the Mexican regulatory agency for approval to commercialize the newest products derived from the Company's PREtec technology platform (Vaccines for PlantsTM), PHC25279 and PHC68949, for use on major crops. 

 

PHC25279 helps control a broad spectrum of plant diseases when used as part of an integrated disease control program and is expected to find immediate application for the control of Gray Mold (Botrytis cinerea) in berries, Downy Mildew (Pseudoperonospora cubensis) in cucurbits such as cucumbers and Late Blight (Phytothphora infestans) in tomatoes and other Solanaceae crops. The current planted area in Mexico for berries totals 55,000 hectares. The production of cucumbers in Mexico is expected to reach 1.02 million metric tons by 2026. Additional PHC25279 product label claims against various other plant pathogens will be added in the future. 

 

PHC68949 is a novel product that amplifies a plant's natural defense pathways to provide protection against plant parasitic nematodes which damage plant roots and limit crop yield. As a next generation bionematicide, PHC68949 increases plant health and yield across a wide range of commercial crops. Results from field studies confirm the efficacy from foliar applications of PHC68949 is comparable to synthetic chemical nematicides and superior to current biological products. PHC68949 is expected to find immediate use in tomatoes, eggplants, peppers and other crops within the Solanaceae family and in cucurbits to protect against yield and quality losses caused by root knot nematodes (Meloidogyne spp.) and other pathogenic nematode species. Mexico's 2023 fresh tomato production is forecasted to reach 3.4 million metric tons (MMT). Additional PHC68949 product label claims against plant parasitic nematodes will be added in the future. 

 

Both products are based on the Company's PREtec technology platform (Vaccines for PlantsTM). Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates plant defense and pathogen resistance mechanisms within plants, resulting in improved crop growth and quality along with the ability to withstand a variety of abiotic stresses. PHC25279 and PHC68949 represent unique products from this platform which provide specific benefits of improved disease and nematode control, plant health and yield. PREtec peptides are compatible with mainstream agricultural practices and common IPM (Integrated Pest Management) and resistance management practices.

 

The regulatory process in Mexico for agricultural products involves a detailed and comprehensive review of standard data requirements. Upon approval, the Federal Committee for Protection from Sanitary Risks (COFEPRIS) will issue Federal Registration. Although COFEPRIS does not commit to a specific timeline for granting regulatory licenses, the Company expects the review to start soon and to receive regulatory approvals within 1-2 years.

 

Plant Health Care continues to expand into new markets around the world and is growing its relationships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025 through the launch of new products and continued organic business growth through current and future distributor relationships.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Ranking 11th in global food production, Mexico provides a tremendous opportunity for the adoption of these new products to support sustainable agriculture. Building on the current success of our ProAct biostimulant, our dedicated team in Mexico is already laying the groundwork for the commercial launch of these two new products once the regulatory licenses are granted. These registration submissions are key steps for Plant Health Care in meeting our $30 million revenue target by 2025."

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

+1 919 926 1600

Cavendish Securities plc - Nomad & Broker Neil McDonald / Pete Lynch

+44 (0) 131 220 9771

SEC Newgate - Financial Communications Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAPBSGDCBSDDGXD
Date   Source Headline
5th May 200611:15 amRNSEGM and Myconate Update
25th Apr 200612:07 pmRNSHolding(s) in Company
12th Apr 20061:30 pmRNSDirector/PDMR Shareholding
10th Apr 20067:02 amRNSSecondary Placing
10th Apr 20067:02 amRNSFinal Results
13th Mar 20067:01 amRNSMyconate - test results
6th Mar 20064:01 pmRNSAppt of Finance Director
25th Jan 20067:01 amRNSTrading Update
15th Dec 20057:00 amRNSMyconate Test Results
3rd Nov 20057:00 amRNSResearch Agreement
20th Sep 200510:56 amRNSDirectors' Holdings
19th Sep 20057:02 amRNSLicensing Agreement
19th Sep 20057:01 amRNSInterim Results
12th Sep 20059:01 amRNSNotice of Results
30th Aug 20057:03 amRNSContract Win
15th Aug 20051:49 pmRNSHolding(s) in Company
4th Aug 20057:00 amRNSNew Product Launch
22nd Jul 20057:00 amRNSDirectorate Change
18th Jul 200510:25 amRNSHolding(s) in Company
4th Jul 20051:24 pmRNSCoSec Change & Share Listing
24th Jun 20053:54 pmRNSDirector Shareholding
13th Jun 20057:01 amRNSDirector Shareholding
10th Jun 200512:51 pmRNSAGM Statement
1st Jun 20057:02 amRNSNew Partnership Initiative
29th Apr 20055:05 pmRNSDirector Shareholding
26th Apr 20057:01 amRNSFinal Results
13th Apr 20057:00 amRNSNew Contract
21st Mar 20053:59 pmRNSDirector Shareholding
7th Mar 20057:02 amRNSTrading Statement
31st Jan 20057:04 amRNSPHC wins tree care trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.